BPMC — Blueprint Medicines Cashflow Statement
0.000.00%
Last trade - 00:00
- $5.32bn
- $4.85bn
- $249.38m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -348 | 314 | -644 | -558 | -507 |
Depreciation | |||||
Non-Cash Items | 54.7 | 82.2 | 363 | 97.3 | 99.6 |
Other Non-Cash Items | |||||
Changes in Working Capital | 9.72 | -15.6 | -23.7 | -53.8 | -41.1 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -278 | 387 | -299 | -502 | -437 |
Capital Expenditures | -14 | -3.16 | -3.09 | -8.92 | -16.1 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -2.45 | -431 | -223 | -141 | 290 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -16.5 | -434 | -226 | -150 | 274 |
Financing Cash Flow Items | -0.4 | 0 | 0 | 416 | -0.044 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 341 | 618 | 50.7 | 562 | 119 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 46.2 | 570 | -475 | -90.2 | -43.4 |